Eleven patients with pancreatic exocrine insufficiency were given daily pancreatic enzyme replacement therapy and 4 patients with new-onset diabetes were given insulin or oral hypoglycemic drugs. The gene discussed is INS; the disease is exocrine pancreatic insufficiency.